News Announcement

Ajanta Pharma: Board Meeting Outcome for Outcome Of Board Meeting For Approving Unaudited Financial Results For Quarter And Half Year Ended 30.09.2024

We hereby inform that the Board at the Board meeting held on Monday 28th October 2024 has inter-alia approved the Unaudited (Consolidated & Standalone) Financial Results of the Company for the quarter and half year ended 30.09.2024 and declared 1st interim dividend for FY 2025.PFA enclosed outcome of Board Meeting for more details.


दूसरी कैटेगरी